| Half-life | 85 hours |
| Clearance Route | hepatic |
| Active Metabolites | no |
| Notes | Dose limiting toxicity is neurotoxicity rather than myelosuppression. |
Severity: Severe
Adverse Effects:
Peripheral neuropathy, constipation/ileus, jaw pain, cranial nerve palsies
Contraindications:
Demyelinating Charcot-Marie-Tooth neuropathy
Precautions:
Prevent constipation aggressively; do NOT give intrathecal (fatal).